LTS acquires Sorrel wearable injection device business
The acquisition is a crucial step in LTS' strategy to broaden its portfolio of drug delivery platforms.
The acquisition is a crucial step in LTS' strategy to broaden its portfolio of drug delivery platforms.
Franson will help biopharma clients design a phased approach to inform and execute clinical development plans
Isoproterenol hydrochloride injection is indicated to improve hemodynamic status in patients in distributive shock and shock due to reduced cardiac output
The survey inspected ambulances operating throughout the city
CiRA, Kyoto University and Astellas - Second Phase Joint Research Agreement Signed for Medical Applications of iPS Cells
Bourgoin early development hub broadens offerings for oral solid dose formulations
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
Government hospitals like AIIMS, KGMC & many more as per day OPD patients are 18-25 thousand
The summit encompasses multiple verticals, spanning from pharmaceuticals, biotech, life sciences, and the Healthcare sector to ensure an unbiased and comprehensive view on the future of the function.
Subscribe To Our Newsletter & Stay Updated